Literature DB >> 29490175

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

.   

Abstract

Entities:  

Year:  2018        PMID： 29490175     DOI： 10.1056/NEJMx180007

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Novel Agents in Multiple Myeloma.

Authors:  Raphaël Szalat; Nikhil C Munshi
Journal:  Cancer J       Date:  2019 Jan/Feb       Impact factor: 3.360

2.  Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery.

Authors:  Liwei Jiang; Sungwook Jung; Jing Zhao; Vivek Kasinath; Takaharu Ichimura; John Joseph; Paolo Fiorina; Andrew S Liss; Khalid Shah; Nasim Annabi; Nitin Joshi; Tomoya O Akama; Jonathan S Bromberg; Motohiro Kobayashi; Kenji Uchimura; Reza Abdi
Journal:  Nano Today       Date:  2020-12-14       Impact factor: 20.722
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.